OrVance Orthodontic Product White Papers

OrVance’s leadership team and advisors have worked with industry experts to publish an Orthodontic Resident Program Lunch & Learn Presentation, a Coalition Letter to the U.S. FDA & FTC advocating for industry compliance, and four whitepapers since the launch of OrthoDots® CLEAR in 2017.

 

OrVance’s Orthodontic Resident Program Presentation [PDF] is given as a Lunch & Learn session in conjunction with the OrthoDots® CLEAR FREE Product Program. This presentation has been well received and has already been presented to the majority of Resident Programs in the U.S.. The presentation covers the performance, aesthetic, quality, safety, and compliance benefits of OrthoDots® CLEAR, and educates our next generation of orthodontists about noncompliant products that should no longer be dispensed to patients.

 

In May 2020, OrVance sent a Coalition Letter [PDF] to the FDA, FTC, and U.S. Customs and Border Protection to request enforcement against the manufacturers, importers, and suppliers of dental wax that continue to blatantly violate current quality and regulatory standards. This letter included support from over 100 orthodontists and dentists.

 

The December 2019 white paper, “Research Concludes Dental Wax Dispensed to Patients Violates Regulatory Requirements in the U.S. and European Union [PDF],” explains how most of the conventional dental wax dispensed to patients violates medical device regulations, and why suppliers must immediately comply with these regulations to protect patient safety and preserve the public’s trust in the orthodontic profession.

 

The July 2019 white paper, “Consumer Alert on Generic Dental Wax [PDF],” explains why several quality and safety features have been in place for over 25 years and why patients should not continue to use dental wax that is in violation of these basic quality standards.

 

1/2 Orthodontic White Papers by OrVanceThe May 2018 white paper, “OrthoDots® CLEAR: Raising the Bar in Quality, Safety, and Compliance [PDF],” compares OrthoDots® to commodity wax in the three aforementioned arenas, concluding that traditional dental wax is no longer up to the quality and safety standards of other healthcare products that are sold to consumers or used in a healthcare setting.

 

1/2 Orthodontic Product White Papers by OrVance

Published in November 2017, “Why OrthoDots® CLEAR Is Poised to Replace Dental Wax [PDF]” is an introduction to the dental wax market in general and OrthoDots® CLEAR in particular. It goes into detail comparing the features and benefits of this new, innovative product to traditional dental wax — and explains why OrthoDots® are a CLEAR upgrade to commodity dental wax, both for patients and orthodontists.

 

Contact us for more information on why OrthoDots® CLEAR are the future of orthodontic treatment, or learn where to buy, whether you’re a patient or an orthodontist.